drugset / Trial / NCT01271478
Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study was to compare the dual use of telmisartan and captopril vs the individual use of such drugs and placebo on the systemic inflammation of patients on hemodialysis (HD).
Timeline
- Start
- 2009-08
- Primary completion
- 2010-12
- Completion
- 2013-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Captopril | Small molecule | 25 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |